New York

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Alopecia areata1 trial
• Childhood cancers1 trial
• Glioblastoma1 trial
• Hypertrophic cardiomyopathy1 trial
• Kidney cancer1 trial
• Melanoma1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Bristol-Myers Squibb4 trials
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Running trials

• Not yet recruiting

  A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)

  NCT07848295· Phase 1· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

  Contact: Site 0024

• Active, not recruiting

  A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

  NCT06253221· Phase 3· Bristol-Myers Squibb· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Kidney cancer1 recruiting

Closed trials

• Terminated

  A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

  NCT05556265· Phase 2· Bristol-Myers Squibb· Source

• Completed

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

  NCT02667587· Phase 3· Bristol-Myers Squibb· Source

• Completed

  Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

  NCT02388906· Phase 3· Bristol-Myers Squibb· Source